Mersana Therapeutics, Inc. (MRSN)
NASDAQ: MRSN · Real-Time Price · USD
6.81
+0.74 (12.19%)
At close: Aug 13, 2025, 4:00 PM
6.80
-0.01 (-0.15%)
Pre-market: Aug 14, 2025, 8:47 AM EDT
Mersana Therapeutics Employees
Mersana Therapeutics had 102 employees as of December 31, 2024. The number of employees decreased by 21 or -17.07% compared to the previous year.
Employees
102
Change (1Y)
-21
Growth (1Y)
-17.07%
Revenue / Employee
$340,873
Profits / Employee
-$725,853
Market Cap
33.95M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
MRSN News
- 21 hours ago - Mersana Therapeutics, Inc. (MRSN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Mersana Therapeutics Provides Business Update and Announces Second Quarter 2025 Financial Results - GlobeNewsWire
- 8 days ago - Mersana Therapeutics to Host Second Quarter 2025 Conference Call on August 13, 2025 - GlobeNewsWire
- 21 days ago - Mersana Therapeutics Announces 1-for-25 Reverse Stock Split - GlobeNewsWire
- 2 months ago - Mersana Therapeutics Reports Additional Positive Interim Phase 1 Clinical Data for Emi-Le in Oral Presentation at 2025 ASCO Annual Meeting - GlobeNewsWire
- 3 months ago - Mersana Therapeutics to Present at Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Mersana Therapeutics, Inc. (MRSN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - CORRECTION - Mersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial Results - GlobeNewsWire